Revenue
9.1 million USD
2026 Q3 · USD
Exact inputs and evidence
- Revenue: 9098000 USD Source
Market value
$159.04M
16,601,411 shares as of 2026-11-06, at $9.58 a share (STRO, IEX close on 2026-11-12) Primary-source evidence
Annual consolidated revenue for 2025: about USD 102.5M, using the latest filing vintage with reviewed corrections applied. Corrected values apply reviewed corrections and remain separate from issuer reports. The previous period, 2024, was about USD 62.04M.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
Window: transactions dated on or after 2025-11-22.
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
9.1 million USD
2026 Q3 · USD
-241.33%
2026 Q3 · %
-22.5 million USD
2026 Q3 · USD
46851000 USD
4061000 USD
16598678 shares
-80.50% · -68.5 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
45.1 million USD
2025-10-01 – 2026-09-30
-155 million USD
2025-10-01 – 2026-09-30
-129 million USD
2025-10-01 – 2026-09-30
Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.
Latest filing recorded: 2026-11-12.
Financial data available through: 2025-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 62.04 million
–
Current period
USD 102.48 million
–
102484000 − 62043000 = 40441000 USD
62043000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source102484000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 227.46 million
–
Current period
−USD 191.09 million
–
-191086000 − -227461000 = 36375000 USD
-227461000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-191086000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 191.54 million
–
Current period
−USD 177.23 million
–
-177231000 − -191540000 = 14309000 USD
-191540000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-177231000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2016 2016-01-01 – 2016-12-31 | 59731000 | 58367000 Derived | 1364000 | -338000 Derived | 1702000 | -17547000 Derived | Source
|
| 2017 2017-01-01 – 2017-12-31 | 51741000 | 71013000 Derived | -19272000 | 416000 Derived | -19688000 | -40389000 Derived | Source
|
| 2018 2018-01-01 – 2018-12-31 | 38419000 | 75642000 Derived | -37223000 | -1906000 Derived | -35317000 | 11126000 Derived | Source
|
| 2019 2019-01-01 – 2019-12-31 | 42736000 | 98204000 Derived | -55468000 | 63736000 Derived | -119204000 | Unavailable | Source
|
| 2020 2020-01-01 – 2020-12-31 | 42722000 | 113779000 Derived | -71057000 | -38929000 Derived | -32128000 | Unavailable | Source
|
| 2021 2021-01-01 – 2021-12-31 | 61880000 | 160404000 Derived | -98524000 | 7014000 Derived | -105538000 | Unavailable | Source
|
| 2022 2022-01-01 – 2022-12-31 | 67772000 | 196715000 Derived | -128943000 | -9739000 Derived | -119204000 | Unavailable | Source
|
| 2023 2023-01-01 – 2023-12-31 | 153731000 | 243009000 Derived | -89278000 | 17515000 Derived | -106793000 | Unavailable | Source
|
| 2024 2024-01-01 – 2024-12-31 | 62043000 | 300496000 Derived | -238453000 | -10992000 Derived | -227461000 | Unavailable | Source
|
| 2025 2025-01-01 – 2025-12-31 | 102484000 | 260851000 Derived | -158367000 | 32719000 Derived | -191086000 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Revenue | 59731000 |
|
| 2017 | Revenue | 51741000 |
|
| 2018 | Revenue | 38419000 |
|
| 2019 | Revenue | 42736000 |
|
| 2020 | Revenue | 42722000 |
|
| 2021 | Revenue | 61880000 |
|
| 2022 | Revenue | 67772000 |
|
| 2023 | Revenue | 153731000 |
|
| 2024 | Revenue | 62043000 |
|
| 2025 | Revenue | 102484000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Year over year | No prior comparable period |
|
| 2017 | Year over year | -13.4% |
|
| 2018 | Year over year | -25.7% |
|
| 2019 | Year over year | 11.2% |
|
| 2020 | Year over year | -0% |
|
| 2021 | Year over year | 44.8% |
|
| 2022 | Year over year | 9.5% |
|
| 2023 | Year over year | 126.8% |
|
| 2024 | Year over year | -59.6% |
|
| 2025 | Year over year | 65.2% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Operating margin | 2.3% |
|
| 2017 | Operating margin | -37.2% |
|
| 2018 | Operating margin | -96.9% |
|
| 2019 | Operating margin | -129.8% |
|
| 2020 | Operating margin | -166.3% |
|
| 2021 | Operating margin | -159.2% |
|
| 2022 | Operating margin | -190.3% |
|
| 2023 | Operating margin | -58.1% |
|
| 2024 | Operating margin | -384.3% |
|
| 2025 | Operating margin | -154.5% |
|
| 2016 | Net margin | 2.8% |
|
| 2017 | Net margin | -38.1% |
|
| 2018 | Net margin | -91.9% |
|
| 2019 | Net margin | -278.9% |
|
| 2020 | Net margin | -75.2% |
|
| 2021 | Net margin | -170.6% |
|
| 2022 | Net margin | -175.9% |
|
| 2023 | Net margin | -69.5% |
|
| 2024 | Net margin | -366.6% |
|
| 2025 | Net margin | -186.5% |
|
| 2016 | Free cash flow margin | -29.4% |
|
| 2017 | Free cash flow margin | -78.1% |
|
| 2018 | Free cash flow margin | 29% |
|
| 2019 | Free cash flow margin | Not reported |
|
| 2020 | Free cash flow margin | Not reported |
|
| 2021 | Free cash flow margin | Not reported |
|
| 2022 | Free cash flow margin | Not reported |
|
| 2023 | Free cash flow margin | Not reported |
|
| 2024 | Free cash flow margin | Not reported |
|
| 2025 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Operating cash flow | -13153000 |
|
| 2017 | Operating cash flow | -37073000 |
|
| 2018 | Operating cash flow | 12683000 |
|
| 2019 | Operating cash flow | -65023000 |
|
| 2020 | Operating cash flow | -67802000 |
|
| 2021 | Operating cash flow | -81679000 |
|
| 2022 | Operating cash flow | 3549000 |
|
| 2023 | Operating cash flow | -111616000 |
|
| 2024 | Operating cash flow | -191540000 |
|
| 2025 | Operating cash flow | -177231000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Free cash flow | -17547000 |
|
| 2017 | Free cash flow | -40389000 |
|
| 2018 | Free cash flow | 11126000 |
|
| 2019 | Free cash flow | Unavailable |
|
| 2020 | Free cash flow | Unavailable |
|
| 2021 | Free cash flow | Unavailable |
|
| 2022 | Free cash flow | Unavailable |
|
| 2023 | Free cash flow | Unavailable |
|
| 2024 | Free cash flow | Unavailable |
|
| 2025 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016-12-31 | Liabilities / assets | Not reported | No source recorded |
| 2017 | Liabilities / assets | 115.9% |
|
| 2018 | Liabilities / assets | 41.1% |
|
| 2019 | Liabilities / assets | 37.5% |
|
| 2020 | Liabilities / assets | 15.7% |
|
| 2021 | Liabilities / assets | 26% |
|
| 2022 | Liabilities / assets | 46.7% |
|
| 2023 | Liabilities / assets | 68.2% |
|
| 2024 | Liabilities / assets | 88.5% |
|
| 2025 | Liabilities / assets | 176.2% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2017 | Current assets / current liabilities | 0.8× |
|
| 2018 | Current assets / current liabilities | 5.76× |
|
| 2019 | Current assets / current liabilities | 3.9× |
|
| 2020 | Current assets / current liabilities | 12.78× |
|
| 2021 | Current assets / current liabilities | 5.24× |
|
| 2022 | Current assets / current liabilities | 5.31× |
|
| 2023 | Current assets / current liabilities | 4.5× |
|
| 2024 | Current assets / current liabilities | 2.6× |
|
| 2025 | Current assets / current liabilities | 2.01× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2016 2016-01-01 – 2016-12-31 | USD 1.7 million Exact valueExact value: 1702000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 13.15 million Exact valueExact value: -13153000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 4.39 million Exact valueExact value: 4394000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 17.55 million Calculation and evidence-13153000 − 4394000 USD Exact free cash flow: -17547000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2017 2017-01-01 – 2017-12-31 | −USD 19.69 million Exact valueExact value: -19688000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 37.07 million Exact valueExact value: -37073000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 3.32 million Exact valueExact value: 3316000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 40.39 million Calculation and evidence-37073000 − 3316000 USD Exact free cash flow: -40389000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2018 2018-01-01 – 2018-12-31 | −USD 35.32 million Exact valueExact value: -35317000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 12.68 million Exact valueExact value: 12683000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.56 million Exact valueExact value: 1557000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 11.13 million Calculation and evidence12683000 − 1557000 USD Exact free cash flow: 11126000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2019 2019-01-01 – 2019-12-31 | −USD 119.2 million Exact valueExact value: -119204000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 65.02 million Exact valueExact value: -65023000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2020-01-01 – 2020-12-31 | −USD 32.13 million Exact valueExact value: -32128000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 67.8 million Exact valueExact value: -67802000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2021-01-01 – 2021-12-31 | −USD 105.54 million Exact valueExact value: -105538000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 81.68 million Exact valueExact value: -81679000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2022-01-01 – 2022-12-31 | −USD 119.2 million Exact valueExact value: -119204000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 3.55 million Exact valueExact value: 3549000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2023-01-01 – 2023-12-31 | −USD 106.79 million Exact valueExact value: -106793000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 111.62 million Exact valueExact value: -111616000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2024-01-01 – 2024-12-31 | −USD 227.46 million Exact valueExact value: -227461000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 191.54 million Exact valueExact value: -191540000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2025-01-01 – 2025-12-31 | −USD 191.09 million Exact valueExact value: -191086000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 177.23 million Exact valueExact value: -177231000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
51 filings · 2,346 latest values · 2,346 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001382101, 1382101, STRO, edgar:1382101
Also known as Fundamental Applied Biology Inc, SUTRO BIOPHARMA INC, SUTRO BIOPHARMA, INC.